Diabetes drug shows promise for PCOS in new study
NCT ID NCT05966792
First seen Apr 30, 2026 · Last updated Jun 14, 2026 · Updated 11 times
Summary
This study looked at whether a type of diabetes drug called SGLT2 inhibitors can help women with Polycystic Ovary Syndrome (PCOS) better than the standard drug metformin. The researchers believe these drugs may work by reducing inflammation in the body. The study involved 82 women aged 18-45 with PCOS and a BMI of 20 or higher, and measured changes in menstrual cycles and markers of inflammation.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POLYCYSTIC OVARY SYNDROME are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Shanghai Tenth People'S Hospital
Shanghai, Shanghai Municipality, 200072, China
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.